Krilogy Financial LLC Buys Shares of 5,714 Tenet Healthcare Corporation $THC

Krilogy Financial LLC purchased a new stake in Tenet Healthcare Corporation (NYSE:THC) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 5,714 shares of the company’s stock, valued at approximately $1,192,000.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. William B. Walkup & Associates Inc. acquired a new stake in Tenet Healthcare in the third quarter valued at approximately $32,000. Canada Pension Plan Investment Board acquired a new stake in shares of Tenet Healthcare during the 2nd quarter valued at $35,000. Westside Investment Management Inc. grew its position in Tenet Healthcare by 100.0% during the 3rd quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock worth $39,000 after acquiring an additional 96 shares during the last quarter. Trust Co. of Vermont acquired a new position in Tenet Healthcare in the 3rd quarter worth about $41,000. Finally, Caitong International Asset Management Co. Ltd boosted its stake in shares of Tenet Healthcare by 2,227.3% during the second quarter. Caitong International Asset Management Co. Ltd now owns 256 shares of the company’s stock valued at $45,000 after purchasing an additional 245 shares in the last quarter. Institutional investors own 95.44% of the company’s stock.

Insider Activity

In other news, Director Nadja West sold 2,178 shares of the firm’s stock in a transaction that occurred on Monday, December 15th. The shares were sold at an average price of $197.47, for a total transaction of $430,089.66. Following the completion of the sale, the director owned 28,480 shares of the company’s stock, valued at $5,623,945.60. This trade represents a 7.10% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Insiders own 0.81% of the company’s stock.

Tenet Healthcare Price Performance

THC stock opened at $232.55 on Friday. The company has a quick ratio of 1.64, a current ratio of 1.76 and a debt-to-equity ratio of 2.18. The firm has a market cap of $20.44 billion, a price-to-earnings ratio of 15.01, a PEG ratio of 0.95 and a beta of 1.44. The company’s fifty day simple moving average is $198.41 and its 200 day simple moving average is $194.17. Tenet Healthcare Corporation has a 12-month low of $109.82 and a 12-month high of $235.77.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, topping the consensus estimate of $4.08 by $0.62. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The firm had revenue of $5.53 billion during the quarter, compared to analyst estimates of $5.47 billion. During the same period last year, the company posted $3.44 EPS. The business’s quarterly revenue was up 8.9% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. On average, analysts expect that Tenet Healthcare Corporation will post 12.24 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms have recently issued reports on THC. Truist Financial reaffirmed a “buy” rating and issued a $240.00 price objective (up previously from $225.00) on shares of Tenet Healthcare in a research note on Monday, November 3rd. Guggenheim upped their price target on shares of Tenet Healthcare from $238.00 to $257.00 and gave the company a “buy” rating in a research report on Tuesday, December 2nd. Wall Street Zen upgraded shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a report on Saturday, January 31st. Cantor Fitzgerald increased their price objective on Tenet Healthcare from $190.00 to $245.00 and gave the company an “overweight” rating in a report on Wednesday, October 29th. Finally, Wells Fargo & Company cut their target price on Tenet Healthcare from $252.00 to $229.00 and set an “overweight” rating on the stock in a report on Wednesday, January 7th. One research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $241.00.

More Tenet Healthcare News

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Q4 beat and strong results: Tenet reported $4.70 EPS vs. $4.08 est. and $5.53B revenue (up ~8.9% YoY); management highlighted revenue and EBITDA growth that underpins the market rally. Tenet Reports Strong Fourth Quarter and FY 2025 Results; Provides 2026 Financial Outlook
• Positive Sentiment: Raised 2026 outlook: Tenet issued EPS guidance of $16.19–$18.47 and an adjusted EBITDA target of $4.485B–$4.785B, signaling confidence in cash flow and M&A optionality. Tenet Healthcare outlines $4.485B–$4.785B 2026 adjusted EBITDA target amid structural cost initiatives and M&A focus
• Positive Sentiment: Analyst upgrade/price-target lift: Jefferies raised its price target to $265 and keeps a Buy rating, providing additional analyst support for further upside. Jefferies Raises Price Target to $265 (Benzinga)
• Positive Sentiment: Market reaction: Shares hit a new one‑year/all‑time high on the beat and outlook, indicating strong investor appetite after the results. Tenet Healthcare (NYSE:THC) Hits New 1-Year High on Better-Than-Expected Earnings
• Neutral Sentiment: Full earnings materials and call transcripts are available for deeper review (slides and transcript show drivers behind the guide and cost initiatives). Tenet Healthcare Corporation 2025 Q4 – Results – Earnings Call Presentation
• Negative Sentiment: Policy headwind: Tenet expects about a $250M hit this year from the loss of ACA subsidies, a near‑term earnings and cash‑flow headwind investors must account for. Tenet expects $250M hit from loss of ACA subsidies this year
• Negative Sentiment: Margin risk for 2026: Some analysts note the guidance midpoint implies potential pressure on 2026 EBITDA margins even as revenue guidance was lifted — monitor margin execution and cost initiatives closely. Tenet Healthcare Beats Q4 Earnings: But 2026 EBITDA Margin May Decline

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.